Novo Nordisk’s Wegovy and copyright, each powered by semaglutide, have revolutionized weight problems treatment by way of unparalleled weight loss final results.In October 2024, Novo Nordisk posted a study on scientific journal Nature a couple of novel glucose-delicate insulin NNC2215 that can decrease the chance of hypoglycemia in animal types.[